2005
DOI: 10.4065/80.3.390
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Myeloid Leukemia: Current Application of Cytogenetics and Molecular Testing for Diagnosis and Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
34
0
11

Year Published

2007
2007
2013
2013

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(45 citation statements)
references
References 164 publications
0
34
0
11
Order By: Relevance
“…Different from, for example, chronic myeloid leukemia where the formation of specific translocation chromosomes is accepted as being crucial for tumor development (Tefferi et al, 2005), the role of most chromosomal aberrations in solid tumors is still elusive. This is also the case for the aberrations identified for the different tumor-derived cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…Different from, for example, chronic myeloid leukemia where the formation of specific translocation chromosomes is accepted as being crucial for tumor development (Tefferi et al, 2005), the role of most chromosomal aberrations in solid tumors is still elusive. This is also the case for the aberrations identified for the different tumor-derived cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…2 There are many laboratory techniques available to detect and quantify minimal residual disease, including standard cytogenetics, fluorescence in situ hybridization, and polymerase chain reaction (PCR)-based detection of residual malignant cells. 3 Classic cytogenetics (chromosome G-banding) is still considered essential to establish a new diagnosis of CML. In addition to its high specificity in detecting the presence of the t(9;22) translocation, this technique provides the benefit of uncovering other chromosomal abnormalities, thus allowing for more reliable prognostication.…”
mentioning
confidence: 99%
“…In CML, modern D-FISH strategies use a "green" probe to identify BCR and a "red" one to highlight ABL. A yellow signal indicates the presence of a BCR-ABL fusion sequence (Tefferi, 2005). This technique allows to detect not only the presence, but also the copy number of the fusion gene on the Ph, as well as the number of any additional BCR-ABL-bearing chromosomes, such as the ones resulting from variant translocations, cryptic translocations or insertions (Dewald, 1998).…”
Section: Fishmentioning
confidence: 99%